Stock Ticker

  • Loading stock data...

Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) Delivers 10,000 COVID-19 Doses in Chile As Vaccination Commences

Chile has received 10,000 initial doses of the Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) COVID-19 vaccine and commenced vaccinations. The county becomes the first in South America to commence vaccinations against the coronavirus that has so far infected over 584,545 Chileans to date. Chileans skeptical about COVID-19 vaccine The first Chilean to receive the vaccine […]

Johnson & Johnson (NYSE:JNJ) Enrols 45,000 Subjects in the Study of Its Experimental COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE:JNJ) has said that it enrolled around 45,000 participants for its late stage study of its single-dose COVID-19 vaccine candidate and anticipates interim data at the end of January 2021. ENSEMBLE Study enrolls 45,000 participants The pharmaceutical company seems to lag rivals such as Moderna Inc. (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE) in […]

FDA Approves Pfizer Inc.’s (NYSE:PFE) Vaccine Candidate for Emergency Use

On Friday, the FDA granted Pfizer Inc.’s (NYSE:PFE) COVID-19 vaccine Emergency Use Authorization, clearing the path for millions of Americans to start receiving the vaccine immediately. Pfizer’s COVID-19 vaccine receives Emergency Use Authorization in the US The approval is a massive turning point considering the COVID-19 pandemic has claimed over 290,000 lives across the US. […]

Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges

Pfizer Inc. (NYSE:PFE) has announced that it will ship only half of the initially expected coronavirus vaccine doses this year due to supply chain problems. The company is developing a COVID-19 vaccine in partnership with Germany-based BioNTech SE (NASDAQ:BNTX). Pfizer to deliver 50 million vaccine doses this year The pharmaceutical giant has slashed its initial […]

Pfizer Inc. (NYSE:PFE) To Use Own Distribution Channel For COVID-19 Vaccines Instead Of Government Channel

Pfizer Inc. (NYSE:PFE) is planning to go alone to distribute the COVID-19 vaccine in the US once the FDA approves it instead of distributing it through the designated government coordinator.  Officials have questioned whether there is an adequate supply of medical-grade freezers in the US at the point of use for vaccines that need storages […]

Pfizer’s (NYSE:PFE) COVID-19 Trial in Children as Young as 12 Years Draws Mixed Sentiments

Pfizer Inc. (NYSE:PFE) recently announced an expansion to its COVID-19 vaccine trial to include teenagers and children of 12 years. The company is the first drugmaker to include children in their COVID-19 vaccine trials, and this has drawn divided reactions from different people. Pfizer testing vaccine in 3,000 teens The New York Pharms received approval […]

Pfizer Inc. (NYSE:PFE) And BioNTech SE (NASDAQ:BNTX) Commences COVID-19 Vaccine Trials In Teenagers and Children

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have received approval from the FDA to test their COVID-19 vaccine candidate in children beginning from 12 years. According to the trial’s lead researcher already parents have shown interest in enrolling children in the study. Pfizer and BioNTech start testing COVID-19 vaccine in kids The trial’s expansion to […]

Pfizer Inc. (NYSE:PFE) And BioNtech (NASDAQ:BNTX) Partners With Rentschler To Purify mRNA-Based COVID-19 vaccine

Pfizer Inc. (NYSE:PFE) and BioNtech (NASDAQ:BNTX) have partnered with Germany contract development band manufacturing organization, Rentschler Biopharma. The partnership is for the purification process of their mRNA-based SARS-CoV-2 vaccine, BMNT1762b2. Rentschler to purify Pfizer and BioNtech’s COVID-19 vaccine drug substance The companies are conducting late-stage clinical studies of the vaccine and expect to release data […]

Pfizer Inc.’s (NYSE:PFE) Transforming Into An Integrated and Collaborative Intelligence Company

Over the past decade, Pfizer Inc.’s (NYSE:PFE) data science senior director Chris Kakkanatt has been transforming the company into a collaborative and integrated intelligence entity. This idea has made headlines for years, and with the proliferation of advances and data in machine learning, the objective has become necessary for most organizations. Kakkanatt shared the transformation […]

Moderna Inc. (NASDAQ:MRNA) Releases Positive Data For Its Coronavirus Vaccine Candidate In Human Trials

Moderna Inc. (NASDAQ:MRNA) has released positive data from its first human trials for its COVID-19 vaccine candidate, demonstrating that the healthy volunteers who received the vaccine developed antibody responses. Moderna’s vaccine in humans shows positive immunity response The company which had partnered with the National Institute of Health in developing the vaccine indicated that there […]

Pfizer Inc. (NYSE:PFE) To Merge Its Off-Patent Business With Mylan (NASDAQ:MYL)

There are reports indicating that Pfizer Inc. (NYSE:PFE) wants to merge its off-patent drug operations in a stock deal with generic drug maker Mylan (NASDAQ:MYL) whose market value is estimated at $9.5 billion. Pfizer to get $12 billion from sale of debt The pharmaceutical company is will spin off its new unit so that it […]

TrovaGene Inc (NASDAQ:TROV) Strengthens Board With Appointment Of Dr. Athena Countouriotis

TrovaGene Inc (NASDAQ:TROV) reported the strengthening and expansion of its Board with the election of Athena Countouriotis, M.D., who brings extensive experience leading clinical advancement programs, from preclinical through clinical phases, and approval. During the course of her career, Dr. Countouriotis has been involved in numerous clinical plans, with a focus within oncology that have […]

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) reported that the company has appointed Gregory Naeve, Ph.D., as Chief Business Officer. Dr. Naeve will lead portfolio and product strategy and business development for the firm. The details Rick Fair, the CEO and President of Bellicum, reported that they are thrilled to welcome a leader of Dr. Naeve’s caliber and […]

The Incyte Rheumatoid Arthritis Pill Setback Poses Disagreements With FDA, As Pfizer Inc (NYSE:PFE) And Others Stand To Gain

The recent turn of events in some of the top stocks have raised eyebrows worldwide, but what Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) have become the highest talk cutting through the air! The two chose Friday, which as a matter of fact happens to be a market holiday to actually disclose the […]

Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND)

Pfizer Inc. (NYSE:PFE) was the winner of a $40 million bid by BIND Therapeutics Inc (NASDAQ:BIND). PFE succeeded at a Section 363 auction initiated by the Cambridge, Massachusetts-based biotechnology company which is selling off its assets. Among other two unidentified companies that had joined the auction Pfizer’s bid was selected as the highest and best. […]